In CCL39 cells thrombin is a potent growth factor which requires sustained activation of mitogen activated protein kinases (MAPKs) to promote DNA synthesis. Some of the eects of thrombin can be mimicked by peptides based on the new amino terminus of the cleaved receptor; however, these thrombin receptor peptides (TRPs) fail to induce sustained activation of MAPK or DNA synthesis. We have used thrombin, TRP-7 and other agonists which elicit sustained or transient MAPK activation to identify immediate-early and delayed-early genes which are only expressed under conditions of sustained MAPK activation focusing on cyclin D1, p21
Introduction
The Ras-regulated Raf-MEK-MAPK/ERK protein kinase cascade plays an important role in the control of cell proliferation and dierentiation (Cobb et al., 1994; Johnson and Vaillancourt, 1994; Hill and Treisman, 1995; Karin and Hunter, 1995; Marshal 1995; Treisman 1996; Whitmarsh and Davis, 1996) . The importance of this pathway for cell growth has been demonstrated by studies showing that activating point mutations in Ras , Raf (Howe et al., 1992; Kyriakis et al., 1992) or MEK (Cowley et al., 1994) are sucient to activate MAPK/ ERK, induce gene expression and cause oncogenic transformation whereas inhibition of this pathway inhibits cell growth (Pages et al., 1993) . Activated MAPK accumulates in the nucleus (Chen et al., 1992; Lenormand et al., 1993) where it regulates the activity of transcriptional regulators such as Elk-1 which in turn drive the expression of immediate early genes such as c-Fos (Gille et al., 1995; Treisman, 1994 Treisman, , 1996 Marais et al., 1993; Whitmarsh and Davis, 1996, Karin and Hunter, 1995; Marshall, 1995) . In this way the Raf-MEK-MAPK/ERK pathway serves to relay signals from activated cell surface receptors into the nucleus to regulate gene expression. Ultimately, activation of this pathway leads to synthesis of the cell cycle regulator cyclin D1 which serves as an allosteric activator of the G 1 -speci®c cyclin-dependent kinases, CDK4 and CDK6. The expression of cyclin D1 is rate-limiting for cell cycle re-entry (Resnitzky et al., 1994) and cyclin D-CDK4 complexes are responsible for phosphorylation and inactivation of the Retinoblastoma tumour suppressor gene (reviewed by Lloyd, 1998; Mittnacht, 1998) .
Several studies have suggested that sustained activation of MAPK/ERK is required for progression through G 1 and entry into S phase. For example, stimulation of CCL39 cells with thrombin, but not the mimetic thrombin receptor peptides (TRPs), leads to a sustained activation of MAPK/ERK; furthermore, thrombin, but not the TRPs, induce DNA synthesis under these conditions (Vouret-Craviari et al., 1993) . In Rat-1 cells mitogenic doses of LPA elicit a sustained activation of MAPK/ERK and promote DNA synthesis whereas non-mitogenic doses of LPA stimulate a transient MAPK/ERK activation (Cook and McCormick, 1996) . Finally, Platelet-derived growth factor (PDGF) induces a sustained activation of MAPK/ERK in IIC9 ®broblasts which correlates with DNA synthesis. Indeed, treatment of IIC9 cells with the MEK inhibitor PD098059, or transfection of a dominant negative MAPK/ERK, inhibits PDGFstimulated sustained MAPK/ERK activation and cell cycle re-entry (Weber et al., 1997) .
Sustained activation of MAPK/ERK is also required for the dierentiation of some cell types. For example, in the PC12 pheochromocytoma cell line nerve growth factor (NGF) stimulates a sustained activation of MAPK/ERK and promotes dierentiation to a sympathetic neuron-like phenotype whereas epidermal growth factor (EGF) or Insulin stimulate a transient activation of MAPK and no dierentiation (Yan and Zi, 1995; Traverse et al., 1994; Dikic et al., 1994) . Furthermore, over-expression of EGF or Insulin receptors in PC12 cells allows reconstitution of sustained MAPK activation and dierentiation when the transfected cells are stimulated with the appropriate growth factor (Traverse et al., 1994; Dikic et al., 1994) .
Since active MAPK accumulates in the nucleus it has been suggested that the duration and magnitude of MAPK activation will direct qualitative changes in gene expression which in turn will determine whether a cell reenters the cell cycle, undergoes cell cycle arrest or remains quiescent (Marshall, 1995) . Logically then, genes which are important for regulating cell cycle progression may be expressed dierentially under these conditions. Indeed, recent studies using titratable, conditional Raf mutants have shown that moderate but sustained activation of MAPK drives expression of cyclin D1 and cell cycle re-entry whereas maximal activation of the pathway additionally drives the expression of p21 Cip1 , an inhibitor of cyclin CDK complexes, thereby causing cell cycle arrest (Woods et al., 1997; Sewing et al., 1997) . These and other studies have identi®ed p21
Cip1 as a gene which is induced by strong and sustained MAPK activation. It is still unclear, however, which transcription factors link sustained MAPK activation to the expression of such genes.
One major target of the MAPK cascade is the dimeric transcription factor AP-1 which is composed of dimers of various combinations of the Fos and Jun family (Angel and Karin, 1991) . The polypeptides encoded by these genes form dimers via a leucine zipper domain whilst the adjacent basic domain binds to a speci®c DNA sequence, TGAC/GTCA known as the TRE (TPA-responsive element) or AP-1 site (Angel et al., 1987) . AP-1/TREs are enhancer elements found in the promoter region of many genes including those involved in cell growth and cell cycle control. The Fos family is made up of four genes (c-Fos, FosB, Fra-1 and Fra-2) whilst the Jun family has three members (cJun, JunB and JunD). Fos and Jun proteins can form heterodimers with Jun and ATF family proteins and Jun proteins can also form homodimers (Hai and Curran, 1991; Halazonetis et al., 1988; Rauscher et al., 1989) . Dierent AP-1 dimer combinations and the surrounding DNA sequence determine the anity for a given TRE (De Cesare et al., 1995; Halazonetis et al., 1988; Hawker et al., 1996) . Furthermore, the transcriptional activity and biological half life of some Fos and Jun proteins is regulated by phosphorylation giving rise to dimers with dierent transactivation properties (reviewed by Karin and Hunter, 1995; Whitmarsh and Davis, 1996) . Finally, the expression level of Fos and Jun proteins changes as a function of time and stimulus (Sonnenberg et al., 1989; Morgan and Curran, 1989; Bravo, 1991, 1992; Lallemand et al., 1997; Cook et al., 1999) making AP-1 a versatile, dynamic transcriptional complex responsive to various environmental cues.
In the context of cell cycle re-entry AP-1 has been implicated in regulating the expression of cyclin D1. The promoter of cyclin D1 contains a canonical AP-1 site which binds to c-Fos and the three Jun proteins and is required for activation of the promoter by RasV12 (Herber et al., 1994; Albanese et al., 1995) . However, c-Fos expression is a transient event which is not required for the proliferation of ®broblasts or many other cell types (Brusselbach et al., 1995; Hu et al., 1994) and selective activation of the MAPK pathway promotes cyclin D1 expression and cell cycle re-entry (Woods et al., 1997) but not c-Fos expression (Cook et al., 1999 ). Here we demonstrate that expression of cyclin D1, p21 Cip1 and proliferative ecacy correlate precisely with the magnitude of sustained MAPK activation in CCL39 cells and have identi®ed a subset of AP-1 genes which are only expressed when MAPK is activated in a sustained manner.
Results

Sustained activation of MAPK is required for cell cycle re-entry and expression of cyclin D1 in CCL39 cells
It was previously demonstrated that thrombin requires sustained activation of the MAPK cascade to induce cell cycle re-entry as monitored by incorporation of [ 3 H]thymidine into newly synthesized DNA (Pages et al., 1993) . This was based upon the observation that thrombin receptor peptides (TRPs), which mimic the N-terminus of the cleaved thrombin receptor, can reconstitute many of the eects of thrombin but fail to induce sustained MAPK activation or DNA synthesis (Vouret-Craviari et al., 1993) . In principle a comparison between thrombin and TRPs would provide an ideal system with which to identify genes selectively up-regulated by sustained activation of MAPK. However, the inability of TRPs to induce DNA synthesis in CCL39 cells has been called into question (Hung et al., 1992; van Corven et al., 1993) . Consequently, our initial experiments sought to con®rm whether or not TRP-7 is a growth factor in CCL39 cells and whether or not it stimulates sustained MAPK activation.
Serum-starved, con¯uent CCL39 cells were stimulated with maximally eective doses of thrombin or TRP for various timepoints from 5 min to 5 h as indicated. Cells were then lysed and p44MAPK (ERK1) was immunoprecipitated and assayed for activity using MBP as a substrate. The results con®rmed those previously described by Pouyssegur and co-workers (Vouret-Craviaro et al., 1993) . Thrombin stimulated a strong early peak of MAPK activation at 5 min which then declined until 40 min from which point on a second phase was apparent and persisted above basal for at least 5 h (Figure 1a ). In contrast, TRP fully reconstituted the early peak response observed with thrombin but the response was transient; MAPK activity declined to basal levels by 1 h and remained so for the duration of the experiment. In parallel with these experiments we also con®rmed that thrombin was a particularly eective growth factor in these cells as judged by [ little, if any, new DNA synthesis (Figure 1a) . These results con®rm that the inability of TRP to induce DNA synthesis correlates with it's inability to induce sustained MAPK activation.
The disparity between results presented by ourselves and Vouret-Craviari et al. (1993) compared to others (Hung et al., 1992; van Corven et al., 1993) may stem from the use of dierent clones of CCL39 cells. We have previously obtained CCL39 cells from the ATCC and found them to be transformed upon arrival, forming foci at high frequency during routine culture and exhibiting greatly reduced serum requirements for growth (Cook, unpublished observations) . In contrast the studies reported here were performed with stocks of CCL39 cells provided by Pouyssegur and co-workers (Vouret-Craviari et al. 1993) which exhibit low spontaneous transformation frequencies and remain acutely dependent upon serum or exogenously supplied Figure 1 Sustained MAPK activation correlates with proliferative ecacy for a variety of stimuli in CCL39 cells. (a) Con¯uent, serum-starved CCL39 cells were stimulated with 100 nM thrombin or 50 mM TRP-7 for the indicated times. Whole cell detergent lysates were prepared and used to immunoprecipitate p44MAPK which was assayed in the immune complex using MBP as a substrate. (Figure 1b) . FBS was the most eective stimulus followed by thrombin which typically stimulated DNA synthesis up to 60% of the response observed with FBS. In contrast both LPA and EGF were very poor growth factors for the CCL39 cell line. We also stimulated parallel cultures of quiescent, serum-starved CCL39 cells with FBS, thrombin, LPA or EGF for either 5 min (the early peak of MAPK activation) or 5 h (the sustained phase of MAPK activation) and assayed p44MAPK in the immune complex. The results revealed that there was no clear correlation between the magnitude of MAPK activation at 5 min and proliferative ecacy. For example, whilst FBS elicited the greatest response thrombin, LPA and EGF were equally ecacious at activating MAPK at 5 min and yet of these three only thrombin gave a robust stimulation of DNA synthesis. In contrast there was a very clear correlation between DNA synthesis and the sustained phase of MAPK activation; only FBS and thrombin were able to stimulate the sustained activation of MAPK and the relative magnitude of these responses correlated well with their proliferative ecacy. Based on this analysis there appears to be a strong and broadly applicable correlation between sustained MAPK activation and cell cycle re-entry in the CCL39 cell line.
To test the feasibility of identifying genes which are selectively up-regulated in response to sustained MAPK activation we examined the expression of cyclin D1 and p21
Cip1
. Cyclin D1 is a activator of CDK4 and CDK6 which is rate-limiting for cell cycle re-entry (Resnitzky et al., 1994; reviewed by Lloyd, 1998; Mittnacht, 1998) , is induced by selective activation of the MAPK pathway (Woods et al., 1997) and requires functional MEK for its expression (Lavoie et al., 1996) . p21
Cip1 was originally described as an inhibitor of CDKs but more recently has been proposed to act as an assembly factor when present at low stoichiometry in cyclin-CDK complexes (LeBaer et al., 1997) . Inducible expression of both cyclin D1 and p21
Cip1 was clearly observed in response to thrombin and FBS but the response to TRP-7, LPA or EGF was very weak (Figure 2a; Balmanno and Cook, unpublished results) . Furthermore, the expression of cyclin D1 and p21
Cip1 in response to thrombin or FBS was inhibited by pre-treatment of cells with PD098059 ( Figure 2b ), a selective inhibitor of MEK1 which prevents activation of MAPK. These results indicate that expression of both cyclin D1 and p21 Cip1 is dependent upon the MAPK pathway but is only observed in response to growth factors which stimulate the sustained activation of this pathway.
Kinetic analysis of the expression of members of the AP-1 family in thrombin-stimulated CCL39 cells
These results demonstrated that sustained MAPK is required for cell cycle re-entry in CCL39 cells and identi®ed cyclin D1 and p21
Cip1 as cell cycle regulators which are only expressed in response to sustained MAPK activation. However, of equal interest is the identify of those transcription factors which link sustained MAPK activation to expression of cyclin D1 and other cell cycle regulators. To this end we sought to identify transcriptional regulators whose expression was selectively linked to sustained MAPK activation. We focussed our studies on the AP-1 transcription factor family for two reasons. First, the promoter for human cyclin D1 contains an AP-1 site (Herber et al., 1994) which binds c-Fos and the three Cip1 requires sustained MAPK activation in CCL39 cells. (a) Con¯uent, quiescent CCL39 cells were stimulated with 10% FBS, 100 nM Thrombin, 50 mM TRP-7, 10 nM EGF or 100 mM LPA as indicated for 9 or 20 h. (b) Con¯uent serum-starved CCL39 cells were pretreated with or without 40 mM PD098059 for 30 min before being stimulated with 100 nM Thrombin or 10% FBS for 9 or 20 h. In both cases whole cell detergent lysates were prepared, fractionated by SDS ± PAGE and immunoblotted using a mouse monoclonal antibodies to cyclin D1 or p21
Cip1 as described in the Materials and methods. The data are representative of at least three experiments giving similar results. The speci®c bands representing cyclin D1 and p21
Cip1 are indicated by lines on the left Jun proteins and is required for optimal activation of the cyclin D1 promoter by RasV12 (Albanese et al., 1995) . Second, the individual members of the Fos and Jun family exhibit quite dierent kinetics of expression (transient or sustained) in response to extracellular stimuli (Sonnenberg et al., 1989; Bravo, 1991, 1992; Lallemand et al., 1997; Cook et al., 1999) .
We ®rst de®ned the kinetics of expression of various members of the AP-1 family. For this analysis we focused on c-Fos and c-Jun as the prototypical immediate-early genes and Fra-1, Fra-2 and JunB as members of the AP-1 family which are induced in a more sustained manner Bravo, 1991, 1992; Lallemand et al., 1997; Cook et al., 1999) . Con¯uent, quiescent CCL39 cells were stimulated with a maximally eective dose of thrombin for the indicated times and whole cell detergent lysates prepared as described in the materials and methods section. Samples were then fractionated by SDS ± PAGE, transferred to PVDF membranes and immunoblotted with antibodies speci®c for the individual transcription factors. The results of this analysis are shown in Figure 3 .
c-Fos protein levels were barely detectable in unstimulated CCL39 cells but increased strongly 40 min and 1 h after addition of thrombin; however, this increase was transient as c-Fos levels were reduced again by 3 h and returned to basal levels by 5 h. Increased accumulation of the two Fos-related antigens Fra-1 and Fra-2 was observed after 2 ± 3 h or 40 min respectively after addition of thrombin; however, in contrast to c-Fos, Fra-1 and Fra-2 were induced in a sustained manner so that they were still strongly expressed in the late G 1 phase when c-Fos levels had declined. c-Jun levels increased rapidly in common with c-Fos but the magnitude of increase was much smaller. In addition, c-Jun was expressed in a sustained manner in response to thrombin, in contrast to c-Fos. Finally, the expression of JunB proceeded in a manner similiar to that observed for Fra-1 being induced after a short lag but in a sustained manner.
In the course of these studies we also noted that the protein products of the c-Fos, Fra-1, Fra-2, c-Jun and JunB genes resolved as multiple bands of diering molecular weights by SDS ± PAGE. In the case of cFos these multiple bands were either clearly apparent (Figures 3, 4, 5a and 6a) or resolved as a broad smear (Figures 5b and 7b ) depending on day-to-day variations in gel running conditions. We (Cook et al., 1999) and others (Okazaki and Sagata, 1995; Chen et al., 1996; Lallemand et al., 1997) have shown that this is due to phosphorylation since the apparent molecular weights of the proteins can be shifted down by treatment of lysates with calf intestinal phosphatase. Indeed, it is known that c-Fos, Fra-1, Fra-2 and c-Jun are substrates for MAPKs and stress activated kinases in vitro and probably in vivo (Gruda et al., 1994; Chen et al., 1996; Agrawal et al., 1995; Murakami et al., 1997 ; reviewed by Fuchs et al., 1998) .
The MEK1 inhibitor, PD098059, inhibits expression of both transient and sustained AP-1 proteins
Many studies have demonstrated a role for MAPK in regulating the expression of c-Fos (reviewed by Hill and Treisman, 1995; Treisman, 1994; Whitmarsh and Davis, 1996) . We wished to determine if the expression of other`sustained' AP-1 genes was also regulated by the MAPK pathway. For these and subsequent studies we concentrated our analysis on c-Fos as a typical, transient', AP-1 gene and Fra-1 and JunB as examples of the`sustained' AP-1 genes and made use of PD098059 a selective inhibitor of MEK1 (Alessi et al., 1995) which prevents MAPK activation (Cook et al., 1997) .
Con¯uent and quiescent CCL39 cells were pretreated with 40 mM PD098059 or vehicle control for 30 min before stimulating with thrombin for the indicated times. Whole cell detergent lysates were assayed for p44 MAPK activity or were fractionated by SDS ± PAGE and analysed by Western immunoblotting. PD098059 caused virtually complete inhibition of thrombin-stimulated MAPK activation at all times points tested up to 5 h (Figure 4a ). The thrombin-stimulated transient increase in c-Fos expression was almost completely inhibited by PD098059 treatment and the small amount of c-Fos which was still induced was exclusively of the lowest molecular weight, hypophosphorylated form (Figure 4b ). In the same experiments the later and sustained increase in Fra-1 expression was also strongly inhibited by PD098059 (Figure 4b ). Once again, thrombin stimulated an increase in Fra-1 expression which was predominantly the most heavily phosphorylated, highest molecular weight form whereas the small amount of Fra-1 induced in the presence of PD098059 consisted primarily of the hypophosphorylated forms. These data indicate that a functional MAPK cascade is required for both the expression and phosphorylation of c-Fos and Fra-1. PD098059 also strongly inhibited the expression JunB at all time points tested though in this case the apparent molecular weight of the JunB was unchanged by the drug. In parallel experiments we also observed that the sustained increase in expression of Fra-2 and c-Jun was also dependent upon the MAPK pathway (Balmanno and Cook, unpublished results). In addition we have recently demonstrated that c-Fos, Fra-1, Fra-2, c-Jun and JunB exhibit the same kinetic pattern of expression and dependency on MAPK in response to proliferative doses of LPA in Rat-1 cells (Cook et al., 1999) . Taken together these data indicate that the MAPK pathway is required for the expression of both the early and transient AP-1 proteins such as c-Fos and those which are expressed after a lag and in a sustained manner such as Fra-1 and JunB (Figure 4 ) and c-Jun and Fra-2 (Balmanno and Cook, unpublished results; Cook et al., 1999) .
The ability of PD098059 to inhibit expression of cyclin D1, p21
Cip1 and the AP-1 proteins studied here correlated with the anti-proliferative eects of the drug (Figure 4c ). Pre-treatment of CCL39 cells with 40 mM PD098059 resulted in a substantial though not complete inhibition of thrombin-and serum-stimulated DNA synthesis as assayed by [ 3 H]thymidine incorporation when compared to cells pre-treated with the DMSO vehicle control followed by growth factor. The much weaker induction of DNA synthesis observed in response to LPA or TRP-7 was also inhibited by PD098059.
Thrombin and TRP-7 induce dierent patterns of AP-1 protein expression
We next examined the role of signal duration in the expression of the AP-1 proteins by comparing the pro®le of expression in response to thrombin, which induces a sustained activation of MAPK, or TRP-7 which induces a transient response. Thrombin again induced a strong but transient increase in c-Fos levels which returned to basal by approximately 5 h. In parallel, TRP-7 also clearly induced c-Fos; however, the response was more transient, returning to basal by 3 h, and was slightly reduced in magnitude in comparison to thrombin (Figure 5a) . A far more striking dierence was noted when we examined Fra-1 Figure 4 The expression of early and sustained AP-1 family proteins requires MAPK activation. Con¯uent, quiescent CCL39 cells were pretreated for 15 min with 40 mM PD098059 or vehicle (DMSO) before stimulation with 100 nM thrombin for the indicated times. (a) Whole cell detergent lysates were prepared and used for assay of p44 MAPK in an immune complex kinase assay. [ Regulation of AP-1 by sustained MAPK activation K Balmanno and SJ Cook levels. Thrombin again induced a strong increase in Fra-1 levels detectable after 3 and 5 h whereas TRP-7 induced a barely detectable increase in Fra-1 levels (see also Figure 7b ). Similar results were obtained when we examined JunB levels. Thrombin induced an increase in JunB which was apparent at 40 min and 1 h and continued to increase in magnitude at 3 and 5 h. In contrast TRP-7 induced the expression of JunB at 40 min and 1 h, albeit more weakly, but the response then declined to barely above basal levels by 5 h. In the same series of experiments we observed that TRP-7 was also unable to mimic the sustained, thrombininduced increase in Fra-2 and c-Jun levels (Balmanno and Cook, unpublished results). By comparing the expression pattern observed in response to FBS or thrombin, which induce sustained MAPK activation and DNA synthesis, with that of LPA or EGF which induce transient MAPK activation and no DNA synthesis we found this to be a broadly applicable observation in CCL39 cells. FBS, thrombin or LPA induced c-Fos expression to equal extents whilst the response to EGF was considerably weaker (Figure 5b ). These results indicate that c-Fos induction does not correlate with proliferative ecacy and is observed regardless of whether agonists induce sustained or transient MAPK activation. In contrast the later induction of Fra-1 and JunB at 5 h was only observed in response to FBS or thrombin indicating a strong correlation with sustained MAPK activation and cell proliferation. We have recently performed a Figure 5 The expression of Fra-1 and JunB, but not c-Fos, correlates with sustained MAPK activation and cell cycle re-entry. (a) Con¯uent, quiescent CCL39 cells were stimulated for the indicated times with maximal doses of thrombin (100 nM) or TRP-7 (50 mM). (b) Con¯uent, quiescent CCL39 cells were stimulated for 1 h or 5 h with 10% FBS (F), 100 nM thrombin (T), 100 mM LPA (L) or 100 nM EGF (E). In both cases whole cell detergent lysates were prepared, fractionated by SDS ± PAGE and transferred to PVDF membranes. Western immuno-blots were performed with antibodies speci®c for c-Fos, Fra-1 or JunB. Data are taken from a single experiment representative of at least three giving similar results. The asterisks to the left indicate the position of two non-speci®c bands which run near c-Fos. The speci®c bands representing c-Fos, Fra-1 and JunB are indicated by lines on the right Figure 6 Persistent thrombin activity is required for expression of Fra-1 and JunB but not c-Fos. Con¯uent, quiescent CCL39 cells were stimulated for 1 or 5 h with 100 nM thrombin. Parallel dishes were stimulated for 5 min with 100 nM thrombin at which time medium was removed, cells were washed and medium replaced with fresh serum free medium containing 50 nM hirudin and incubated for a further 55 min or 4 h 55 min. Whole cell detergent lysates were prepared, fractionated by SDS ± PAGE and transferred to PVDF membranes. Western immuno-blots were performed with antibodies speci®c for c-Fos, Fra-1 or JunB. The asterisks to the left indicate the position of two non-speci®c bands which run near c-Fos. The speci®c bands representing c-Fos, Fra-1 and JunB are indicated by lines on the right. Note that although c-Fos is still induced in response to thrombin+hirudin the apparent molecular weight of c-Fos was lower than in the presence of thrombin alone similar analysis in Rat-1 cells where high or low doses of LPA induce either sustained MAPK activation and DNA synthesis or transient MAPK and no cell cycle re-entry. The results are in accord with those described here in as much as Fra-1, Fra-2, c-Jun and JunB are only induced to a signi®cant extent in response to doses of LPA which promote sustained MAPK activation (Cook et al., 1999) .
In summary, our results indicate that whilst the expression of ®ve of the AP-1 proteins requires the activation of MAPK the expression of the`sustained' AP-1 proteins (Fra-1, Fra-2, c-Jun and JunB) requires that MAPK activation persists for several hours whereas c-Fos expression is still readily inducible in response to even transient MAPK activation. Thus, the duration of MAPK activation is a key determinant of the repertoire of AP-1 proteins expressed during growth factor-stimulated cell cycle re-entry in CCL39 cells and Rat-1 cells.
The thrombin inhibitor, hirudin, blocks the expression of Fra-1 and JunB but not c-Fos
The ability of thrombin but not TRP-7 to induce the expression of Fra-1 and JunB could have two explanations. First the proteolytically cleaved thrombin receptor may activate qualitatively dierent signalling pathways which result in sustained MAPK activation compared to the peptide-activated receptor. Alternatively, qualitiatively identical signalling pathways may be activated but the duration of MAPK activation may simply be determined by the duration of receptor activation. For example, the cleaved thrombin receptor is irreversibly activated until it is internalized and degraded whereas the peptide-activated receptor will have a measurable K o and receptor activation will therefore be more transient. To try and dierentiate between these two models we used the thrombin inhibitor hirudin to block thrombin activity 5 min after addition and compared the pattern of gene expression observed with cells which received thrombin alone. In principle, thrombin will be activating the same pool of receptors by the same proteolytic mechanism but for a limited duration.
Control experiments con®rmed that addition of hirudin 5 min after thrombin resulted in the rapid return of MAPK activation to basal levels within 1 h (Balmanno and Cook, unpublished results) as has been observed previously (Meloche et al., 1992) . Thrombin induced the expression of c-Fos after 1 h regardless of the presence or absence of hirudin though the magnitude of c-Fos induction in the presence of hirudin was reduced slightly compared to that with thrombin alone (Figure 6 ). The most striking dierence was that the apparent molecular weight of c-Fos was lower in the presence of hirudin than with thrombin alone. Since MAPK and the MAPK-dependent p90 RSK are known to phosphorylate c-Fos (Okazaki and Sagata, 1995; Chen et al., 1996) this observation may re¯ect the much more transient MAPK activation observed in response to thrombin+hirudin (Meloche et al., 1992; Balmanno and Cook, unpublished results) . In contrast to c-Fos, the induction of Fra-1 was not observed when hirudin was added 5 min after thrombin and the induction of JunB was greatly reduced (Figure 6 ). These results suggest that it is the Figure 7 Thrombin, TRP-7 and LPA activate MAPK and induce gene expression by the same pertussis toxin-sensitive pathway. Con¯uent, quiescent CCL39 cells were pretreated with pertussis toxin at 100 ng/ml overnight before being stimulated with 100 nM Thrombin, 50 mM TRP-7 or 100 mM LPA for 10 min (a) or (b). Thr for c-Fos or 5 h for Fra-1, JunB or Cyclin D1. (a) Whole cell detergent lysates were prepared and used to immunoprecipitate p44MAPK which was assayed in the immune complex using MBP as a substrate. [ Thrombin, TRP-7 and LPA activate MAPK and induce gene expression by the same pertussis toxin-sensitive pathway There are many similarities between the signalling pathways activated by the thrombin receptor and the LPA receptor. Both can couple to the Ras pathway via a pertussis toxin-sensitive, Gi-regulated pathway (van Corven et al., 1993; Cook et al., 1993; Cook and McCormick, 1996) and both can couple to activation of PKC and Ca 2+¯u xes, via a Gq-PLC pathway (PouysseÂ gur and van Corven et al., 1989) . The Gi-Ras pathway seems to be the most important, quantitatively, for MAPK activation whereas the Gq-PLC pathway may make a small but transient contribution (Cook and McCormick, 1996; Kahan et al., 1992) . Since LPA is a poor growth factor and elicits transient MAPK activation in CCL39 cells we wished to see if this was because LPA could not utilise the Gi pathway for MAPK activation. To this end we pre-treated CCL39 cells with or without pertussis toxin for 18 h and then stimulated them with thrombin, TRP-7 or LPA for 5 min. p44MAPK immunecomplex kinase assays revealed that all three agonists activated MAPK in a pertussis toxin-sensitive manner (Figure 7a) . Furthermore, when we pre-treated cells with 1 mM PMA for 48 h to deplete PKC levels this had little if any eect on the activation of MAPK by thrombin, TRP-7 or LPA but completely inhibited the response to PMA (Balmanno and Cook, unpublished results). Thus, thrombin, TRP-7 and LPA activate MAPK by pharmacologically similar pathways, largely via Gi.
Finally, we pre-treated CCL39 cells with or without pertussis toxin, stimulated them for 1 or 5 h with thrombin, TRP-7 or LPA and examined the expression of c-Fos, Fra-1, JunB or cyclin D1 (Figure 7b ). The thrombin-induced expression of c-Fos at 1 h and Fra-1, JunB or cyclin D1 at 5 h was strongly inhibited by pertussis toxin. In common with thrombin the early induction of c-Fos by both TRP-7 and LPA was also strongly inhibited by pertussis toxin. TRP-7 and LPA again gave a very weak induction of Fra-1, JunB or cyclin D1 expression at 5 h but this weak response was inhibited by pertussis toxin. The simplest conclusion from these results is that thrombin, TRP-7 and LPA induce AP-1 and cyclin D1 gene expression by activating the same Gi-regulated pathway and it is the duration for which this pathway is activated that determines the repertoire of AP-1 genes expressed during cell cycle re-entry.
Discussion
Sustained MAPK activation is a common requirement for expression of cyclin D1 and cell cycle re-entry in ®broblasts
In this manuscript we have demonstrated that sustained MAPK activation appears to be a prerequisite for stimulated DNA synthesis in CCL39 cells. This model, originally proposed for thrombin (Vouret-Craviari et al., 1993) , seems to be of general utility since it applies to a variety of dierent agonists in CCL39 cells whether or not they activate receptor tyrosine kinases (EGF) or G-protein coupled receptors (thrombin, TRP-7 or LPA). In all cases agonists which caused only a transient activation of MAPK failed to elicit DNA synthesis whereas thrombin and FBS elicited a biphasic sustained response which persisted for at least 5 h.
We were interested in identifying genes which are selectively up-regulated in response to sustained activation of MAPK and so the CCL39 cell line seemed to be a particularly good system in which to base our studies. To test this premise further we examined the expression of cyclin D1, the growth factor-inducible activator of CDK4 and CDK6, and p21
Cip1 an inhibitor of cyclin-CDK complexes (reviewed by Lloyd, 1998; Mittnacht, 1998) . We found that of all the agonists tested only thrombin and FBS were able to induce expression of cyclin D1 and p21
Cip1
, correlating directly with the duration of MAPK activation and proliferative ecacy of each agonist. Furthermore, the induction of cyclin D1 and p21 Cip1 was clearly, though not completely, inhibited by the MEK1 inhibitor PD098059. A recent study in the IIC9 cell line revealed that PDGF requires the persistent activation of MAPK for cell cycle re-entry and cyclin D1 expression (Weber et al., 1997) whilst in NIH3T3 cells selective, sustained activation of the MAPK pathway using conditional mutants of Raf is, alone, sucient for cyclin D1 expression (Sewing et al., 1997; Woods et al., 1997) . Furthermore, it has previously been shown that PD098059 inhibits activation of the cyclin D1 promoter in CCL39 cells (Lavoie et al., 1996) . Taken together these results indicate that expression of cyclin D1 requires sustained activation of the MAPK pathway.
A number of studies have suggested a correlation between the duration of MAPK activation and cell fate decisions such as cell cycle re-entry or arrest. For example, the PC12 cell line undergoes cell cycle arrest and dierentiation in response to NGF, which induces a robust and sustained activation of MAPK, but not EGF, which induces a transient activation of MAPK (Traverse et al., 1994; Yan and Zi, 1995) . At ®rst sight the correlation between sustained MAPK activation and cell proliferation in ®broblasts or cell cycle arrest in PC12 cells seems somewhat contradictory; however, recent studies have suggested a possible explanation. In NIH3T3 cells conditional mutants of Raf promote a dose-dependent activation of the MAPK pathway (Sewing et al., 1997; Woods et al., 1997) . However, optimal DNA synthesis is induced in response to only a partial, albeit sustained, activation of MAPK. Under these conditions cyclin D1 and E are induced and p27 Kip1 is degraded. Maximal activation of MAPK results in a reduction in DNA synthesis to basal levels due to the additional expression of p21
Cip1 and inhibition of CDKs; thus, expression of cyclin D1 and E respond to a dierent threshold of MAPK activation compared to p21 Cip1 . The ability of growth factors to promote the expression of both cyclin D1 and p21
Cip1 seems contradictory but may be related to the recent proposal that at low stoichiometry p21
Cip1 acts to promote the assembly of cyclin-CDK complexes (LaBaer et al., 1997) . In this way the transient activation of MAPK by TRP-7, LPA or EGF in CCL39 cells and EGF in PC12 cells (Traverse et al., 1994; Yan and Zi, 1995) will correlate with the lack of cyclin D1 induction and cell cycle reentry. Likewise, the more sustained activation of MAPK seen with growth factors (FBS and thrombin in CCL39 cells and LPA in Rat-1 cells (Cook and McCormick, 1996) may support assembly of functional CDK complexes by promoting the expression of cyclin D1 and a modest level of p21
. In contrast, the very robust and persistent activation of MAPK observed in response to NGF in PC12 cells (Traverse et al., 1994; Yan and Zi, 1995) or maximally activated DRaf-1:ER in NIH3T3 cells (Sewing et al., 1997; Woods et al., 1997) will`super-induce' p21
Cip1 leading to inhibition of CDKs and cell cycle arrest. Finally, the ability of the MAPK pathway to drive the expression of p21
Cip1 may be delayed or dampened by additional Ras-dependent pathways operating through the small GTPase RhoA (Olson et al., 1998) .
The demonstration that LPA is a poor growth factor in CCL39 cells came as a surprise since it is a good growth factor for many other cell types (van Corven et al., 1989) . Despite this, the poor ecacy of LPA in CCL39 cells ®ts with our model since it fails to induce sustained MAPK and gives a very weak induction of Fra-1, JunB and cyclin D1 in these cells. The activation of MAPK and cell cycle re-entry in response to thrombin in CCL39 cells is sensitive to pertussis toxin since the major pathway for activation of Ras by these growth factors is regulated by a Gi heterotrimeric GTPase (van Corven et al., 1993) . One possibility for the poor ecacy of TRP-7 and LPA in CCL39 cells is that the LPA receptor and the TRP-7-activated thrombin receptor fail to couple to this Gi pathway. However, our analysis suggests that this is not the case since activation of MAPK by thrombin, TRP-7 or LPA was strongly inhibited by pertussis toxin and this was re¯ected in downstream gene expression. Rather it seems that it is the duration of receptor activation which determines the duration of MAPK activation. This contention is supported by the ability of hirudin to block thrombin induced Fra-1 and JunB expression, but not c-Fos expression, when added 5 min after thrombin. This result indicates that persistent thrombin activity and thrombin receptor activation is required for the sustained activation of MAPK (Meloche et al., 1992) and concomitant expression of Fra-1 and JunB but not c-Fos ( Figure  6 ). In this context it is interesting to note that a mutant EGF receptor which fails to desensitize is able to induce sustained MAPK activation and cell cycle arrest in PC12 cells (Traverse et al., 1994) . Furthermore, the simple over-expression of Insulin receptors confers Insulin-dependent cell cycle arrest upon recipient PC12 cells (Dikic et al., 1994) . These observations together with our studies in CCL39 cells argue that the duration of receptor activation or level of receptor expression can determine the duration of MAPK activation and resultant biological eect. Hence the dierences in LPA-stimulated MAPK activation and proliferative ecacy between CCL39 cells and Rat-1 cells (Cook and McCormick, 1996) may in part re¯ect dierences in receptor number between these two cell types.
Discrete members of AP-1 family are only expressed when MAPK is activated in a sustained manner
Establishing that the expression of cyclin D1 and p21
Cip1 requires sustained MAPK activation raised the question of which transcriptional regulators serve to link these two events. As a ®rst step to addressing this we sought to identify transcription factors which were selectively up-regulated in response to sustained MAPK activation. For this analysis we focussed on the AP-1 family because it has been shown that the human cyclin D1 promoter contains a functional AP-1 site (Herber et al., 1994) which is Ras responsive (Albanese et al., 1995) .
Kinetic analysis using thrombin revealed that the ®ve AP-1 proteins analysed could be divided into two groups based on the kinetics of their expression. c-Fos was induced rapidly but transiently whereas Fra-1, Fra-2 and JunB were induced after a short lag but in a sustained manner; c-Jun fell between the two in as much as it was induced early but in a more sustained manner relative to c-Fos. We have also observed the same expression pattern in Rat-1 cells (Cook et al., 1999) so, for the purposes of this study, we concentrated our analysis on c-Fos, to represent the early and transient AP-1 proteins, and Fra-1 and JunB, as examples of the`sustained' AP-1 proteins.
Our analysis revealed that the expression of c-Fos, Fra-1 and JunB was acutely dependent upon the MAPK pathway since thrombin-stimulated increases in expression were strongly inhibited by PD098059. Preliminary analysis has revealed that the expression of c-Jun and Fra-2 is also dependent upon MAPK (Balmanno and Cook, unpublished observations) and we have observed similar results in Rat-1 cells (Cook et al., 1999) . Based on these results it is likely that inhibition of the MAPK pathway, a focus of current drug discovery eorts, will have a signi®cant eect on AP-1 protein expression.
Whilst the expression of all AP-1 components tested was dependent upon the MAPK pathway we have identi®ed a subset which are only expressed when MAPK is activated in a sustained manner. Thorough kinetic comparisons of thrombin and TRP-7 revealed that c-Fos was induced by both agonists whereas Fra-1 and JunB were only expressed signi®cantly in response to thrombin; similar results were obtained for Fra-2 and c-Jun (Balmanno and Cook, unpublished observations). This correlation was strengthened by examining the response to FBS, LPA and EGF at 1 h and 5 h. Again only FBS, which elicits sustained MAPK, was able to induce a strong expression of Fra-1 and JunB. Based on these results and our recent studies in Rat-1 cells (Cook et al., 1999) we conclude that the expression of Fra-1, Fra-2, c-Jun and JunB requires the sustained activation of MAPK.
The molecular basis for the preferential expression of these genes in response to sustained MAPK activation remains unclear and it would certainly be misleading to assume that regulation is exclusively at the transcriptional level. Phosphorylation of c-Jun by MAPKs and Stress-activated protein kinases (SAPKs) (Musti et al., 1997) and c-Fos by MAPK and the MAPK-dependent p90 RSK (Chen et al., 1996; Okazaki and Sagata, 1995) increases their biological half life and transforming properties (reviewed by Fuchs et al., 1998) . We observed that both Fra-1 and Fra-2 and JunB exhibited heterogeneity in their apparent molecular weights which has been attributed to phosphorylation (Gruda et al., 1994; Murakami et al., 1997) . Future studies will aim to address if sustained MAPK exerts its eect at the transcriptional or post-translational levels in determining the expression of`sustained' AP-1 proteins.
The correlation between sustained MAPK activation, expression of Fra-1, Fra-2, c-Jun and JunB and cell proliferation in CCL39 cells and Rat-1 cells (Cook et al., 1999) raises the question of the role these proteins play in regulating cell cycle re-entry. Ectopic c-Fos expression induces morphological transformation but does so without increasing cell proliferation or cyclin D1 levels (Miao and Curran, 1994) ; furthermore, c-Fos 7/7 mice are viable and c-Fos 7/7 ®broblasts proliferate normally (Brusselbach et al., 1995; Hu et al., 1994) . These observations argue against a role for c-Fos in regulating cell cycle re-entry and our demonstration that c-Fos is induced just as strongly by LPA (a poor growth factor) as it is by thrombin or FBS in CCL39 cells is consistent with this. In contrast to c-Fos and FosB, Fra-1 and Fra-2 are expressed in cycling cells as well as during the transition from quiescence. In addition, micro-injection of neutralizing antisera to any of the Fos proteins has an inhibitory eect on cell proliferation but again only Fra-1 and Fra-2 are required for both exponential growth and stimulated cell cycle re-entry (Kovary and Bravo, 1991; . Fra-1, Fra-2, c-Jun and JunB but not c-Fos have been shown to be upregulated in Ras-transformed (Mechta et al., 1997; Vallone et al., 1997) and Raf or MEK transformed cells (Cook et al., 1999 , Treinies et al., 1999 cells whilst ectopic expression of Fra-1 transforms Rat-1 cells (Bergers et al., 1995) and cooperates with c-Jun in transforming NIH3T3 cells (Mechta et al., 1997) . Based on these observations and the strong correlations we and others have observed (Cook et al., 1999; Treinies et al., 1999) we feel that a further investigation of the role of Fra-1, Fra-2, c-Jun and JunB in regulating cell cycle re-entry and transformation is warranted.
In conclusion our results suggest that the duration of MAPK activation is an important determinant of cell cycle re-entry which directs the expression of cyclin D1, p21
Cip1 and the repertoire of AP-1 genes expressed during cell cycle re-entry. Taken together with other work in the ®eld the correlation between the expression of Fra-1, Fra-2, c-Jun and JunB and sustained MAPK activation suggests that these transcription factors may serve to link sustained MAPK activation to expression of cell cycle regulators. For example, since DRaf-1:ER or MEK:ER can induce the expression of cyclin D1 and cell cycle re-entry without signi®cantly inducing cFos levels (Woods et al., 1997; Cook et al., 1999; Treinies et al., 1999) it may be interesting to examine the role played by these other AP-1 components in the expression of cyclin D1 and other cell cycle regulators.
Materials and methods
Materials
Cell culture reagents were purchased from Gibco Life Technologies, thrombin from bovine plasma, recombinant hirudin, lysophosphatidic acid (LPA) and myelin basic protein were purchased from Sigma. TRP-7 (NH 2 -SFLLRNP-COOH) was synthesized by the Microchemical Facility at the Babraham Institute. PD098059 was purchased from Calbiochem and epidermal growth factor (EGF) from Boehringer Manneheim. Rabbit anti-peptide antisera to cFos, Fra-1, Fra-2 and Jun B were from Santa Cruz Biotchnology, cyclin D1 and p21 cip1 antibodies were from Oncogene Research products and Pharmingen respectively. The c-Jun antipeptide antibody was generously provided by Dr David Gillespie, (CRC Beatson Laboratories, Glasgow). HRP conjugated secondary antibodies were from Bio-Rad and detection of Western blots was with the Enhanced Chemi-Luminescent system (ECL) from Amersham. The antip44MAPK/ERK1 antiserum was raised to the C-terminal peptide (KELIFQETARFQPGAPEAP) coupled to the puri®ed protein derivative of Tuberculin.
Cells and cell culture CCL39 cells are a chinese hamster lung ®broblast cell line which exhibits high serum and anchorage-dependence for growth and has been used extensively for the study of signalling pathways regulating cell cycle re-entry (Pouyssegur and Seuwen 1992; Pages et al., 1993; Vouret-Craviari et al., 1993) . CCL39 cells were a kind gift from Dr Fergus McKenzie and Prof J PouysseÂ gur, Centre de Biochimie, UniversiteÂ de Nice and were maintained in Dulbecco's modi®ed Eagles medium (DMEM) supplemented with 2 mM glutamine, penicillin and streptomycin and 7% (v/v) fetal bovine serum (FBS).
Stimulations and preparation of cell lysates
CCL39 cells were plated into 6 cm dishes (Nunc) and grown to con¯uence. To prepare them for stimulation the growth medium was replaced with serum free DMEM for 24 h to induce a quiescent state. Cells were then stimulated by addition of the appropriate agonists to the dishes. Incubations for the indicated times were at 378C and 5% CO 2 . At the end of the time course medium was aspirated, ice-cold TG lysis buer was added, and dishes placed on ice. Cell extracts were harvested and clari®ed by centrifugation at 14 000 g for 10 min at 48C. Samples were then either prepared for Western blotting by boiling in Laemmli sample buer or used immediately for measurement of p44MAPK (ERK 1) activity.
Western blotting
Equal amounts of cell lysate were fractionated on SDS ± PAGE gels (Hoefer Mighty Small system) and transferred to methanol soaked PVDF membranes at 300 mA for 1 h in a Bio-Rad mini transblot apparatus. After staining with Coommasie Blue to con®rm equal loading, ®lters were incubated in phosphate buered saline with 0.1% (v/v) Tween-20 (TPBS) plus 5% (w/v) powdered milk (TPBS+milk) for at least 1 h before probing with antisera. First and second antibody incubations were performed in TPBS+milk at room temperature for 1 h with six washes during 30 min using TPBS after both ®rst and second antibody. Antibody-antigen complexes were detected using ECL according to the manufacturer's instructions.
p44MAPK (ERK 1) kinase activity
After clari®cation by centrifugation protein estimation of the supernatants was carried out (Bradford) and equal quantities of protein, typically 100 mg, were immunoprecipitated using rabbit ERK1 antiserum and protein A coated sepharose beads. Beads were then washed twice in TG-lysis buer and once in kinase buer (30 mM Tris pH 8; 20 mM MgCl 2 2 mM
